Global X Genomics & Biotechnology ETF (GNOM) News Today $9.18 -0.03 (-0.33%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$9.18 0.00 (0.00%) As of 08/29/2025 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock GNOM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Global X Genomics & Biotechnology ETF declares semi-annual distribution of $0.0083June 30, 2025 | msn.com10x Genomics Misses Revenue ForecastOctober 29, 2024 | fool.comGlobal X Genomics & Biotechnology UCITS ETF (GNOM.L)August 18, 2024 | finance.yahoo.comGNOM Global X Genomics & Biotechnology ETFJuly 25, 2024 | seekingalpha.com3 Gene Editing Stocks with the Potential to Make You an Overnight MillionaireMay 2, 2024 | investorplace.comThe Analyst Landscape: 4 Takes On 10x GenomicsApril 18, 2024 | markets.businessinsider.com3 Stocks That Could Be the Next Big Thing in Gene EditingMarch 21, 2024 | investorplace.comGlobal X Genomics & Biotechnology UCITS ETF (GNOG.L)March 14, 2024 | finance.yahoo.comGlobal X Genomics & Biotechnology ETF (GNOM)March 6, 2024 | investing.comGlobal X Cannabis ETF declares $0.1656 dividendDecember 29, 2023 | msn.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Expands By 47.6%December 14, 2023 | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $4.65 Million Stock Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)August 11, 2023 | marketbeat.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Rises By 44.8%July 17, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Boosts Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)July 12, 2023 | marketbeat.comJames J. Burns & Company LLC Makes New Investment in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)July 7, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Buys 13,244 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)May 28, 2023 | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $6.40 Million Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)May 23, 2023 | marketbeat.comGlobal X S&P 500® Catholic Values ETF (CATH)May 12, 2023 | investing.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Quotes and News SummaryApril 29, 2023 | benzinga.comComplete Genomics Stock Falls On Unusually High Volume (GNOM)April 15, 2023 | thestreet.com15,239 Shares in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Bought by Clearwater Capital Advisors LLCApril 10, 2023 | marketbeat.comSightline Wealth Advisors LLC Grows Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)April 6, 2023 | marketbeat.comPrivate Advisor Group LLC Sells 134,751 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)April 3, 2023 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Holdings Cut by McGuire Investment Group LLCMarch 17, 2023 | marketbeat.comMcGuire Investment Group LLC Sells 266,038 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)March 17, 2023 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Significant Decline in Short InterestMarch 10, 2023 | marketbeat.comUBS Group AG Sells 24,463 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)March 9, 2023 | marketbeat.comMML Investors Services LLC Sells 8,782 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)March 6, 2023 | marketbeat.comNomura Asset Management Co. Ltd. Acquires 49,700 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)February 23, 2023 | marketbeat.comGlobal X Adaptive U.S. Risk Management ETF (ONOF): January 2023 ReportFebruary 16, 2023 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Sold by Banco Santander S.A.February 3, 2023 | marketbeat.comGNOM: Get Exposure To The Latest Genomics And Biotechnology CompaniesJanuary 18, 2023 | seekingalpha.comComplete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023January 10, 2023 | markets.businessinsider.comGlobal X Adaptive U.S. Risk Management ETF (ONOF): November ReportJanuary 6, 2023 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Large Increase in Short InterestDecember 2, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 55.8% in OctoberNovember 11, 2022 | marketbeat.comA Preview Of Singular Genomics Systems's EarningsNovember 4, 2022 | benzinga.comHow To Invest In Genomics And ImmunologyOctober 19, 2022 | seekingalpha.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 60.7% in SeptemberOctober 13, 2022 | marketbeat.com10x Genomics: No Signs Of A Growth Turnaround, Heavy Bearish MomentumOctober 12, 2022 | seekingalpha.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Significant Increase in Short InterestSeptember 28, 2022 | marketbeat.comESMO 2022: REVEAL GENOMICS®️ PRESENTS NEW VALIDATION DATA OF HER2DX®️ IN THE PerELISA TRIALSeptember 12, 2022 | yahoo.comGlobal Optical Genome Mapping Market 2022-2027: Featuring Key Players Bionano Genomics, Nabsys, France Genomique & OthersAugust 8, 2022 | benzinga.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Declines By 23.2%August 1, 2022 | marketbeat.comWhat 5 Analyst Ratings Have To Say About 10x GenomicsJuly 15, 2022 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Up 56.0% in JuneJuly 2, 2022 | marketbeat.comNIH's National Human Genome Research Institute and NSTA Unveil New Genome: Unlocking Life's Code Educational Resources for EducatorsJune 16, 2022 | benzinga.comUltima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated ComputingJune 6, 2022 | markets.businessinsider.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 44.2% in MayMay 28, 2022 | marketbeat.comSightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF,January 26, 2022 | finance.yahoo.com Get Global X Genomics & Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNOM Media Mentions By Week GNOM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNOM News Sentiment▼1.881.31▲Average News Sentiment GNOM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNOM Articles This Week▼10▲GNOM Articles Average Week Get the Latest News and Ratings for GNOM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Democratic Large Cap Core ETF News Today Global X Blockchain & Bitcoin Strategy ETF News Today Roundhill GLP-1 & Weight Loss ETF News Today Tradr 2X Long Innovation ETF News Today First Trust S-Network Future Vehicles & Technology ETF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNOM) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts